Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 100 Records) |
Query Trace: Coronary artery disease and CYP2C19[original query] |
---|
CYP2C19 pharmacogenetics versus standard of care dosing for selecting antiplatelet therapy in patients with coronary artery disease: A meta-analysis of randomized clinical trials. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2018 11 93 (7): 1246-1252. Kheiri Babikir, Osman Mohammed, Abdalla Ahmed, Haykal Tarek, Pandrangi Pranay V, Chahine Adam, Ahmed Sahar, Osman Khansa, Bachuwa Ghassan, Hassan Mustafa, Bhatt Deepak |
Pharmacogenomic polygenic response score predicts ischaemic events and cardiovascular mortality in clopidogrel-treated patients. European heart journal. Cardiovascular pharmacotherapy 2019 Sep . Lewis Joshua P, Backman Joshua D, Reny Jean-Luc, Bergmeijer Thomas O, Mitchell Braxton D, Ritchie Marylyn D, Déry Jean-Pierre, Pakyz Ruth E, Gong Li, Ryan Kathleen, Kim Eun-Young, Aradi Daniel, Fernandez-Cadenas Israel, Lee Ming Ta Michael, Whaley Ryan M, Montaner Joan, Gensini Gian Franco, Cleator John H, Chang Kiyuk, Holmvang Lene, Hochholzer Willibald, Roden Dan M, Winter Stefan, Altman Russ B, Alexopoulos Dimitrios, Kim Ho-Sook, Gawaz Meinrad, Bliden Kevin P, Valgimigli Marco, Marcucci Rossella, Campo Gianluca, Schaeffeler Elke, Dridi Nadia P, Wen Ming-Shien, Shin Jae Gook, Fontana Pierre, Giusti Betti, Geisler Tobias, Kubo Michiaki, Trenk Dietmar, Siller-Matula Jolanta M, Ten Berg Jurriën M, Gurbel Paul A, Schwab Matthias, Klein Teri E, Shuldiner Alan R, |
Impact of Platelet Endothelial Aggregation Receptor-1 Genotypes on Platelet Reactivity and Early Cardiovascular Outcomes in Patients Undergoing Percutaneous Coronary Intervention and Treated With Aspirin and Clopidogrel. Circulation. Cardiovascular interventions 2019 May 12 (5): e007019. Xu Ke, Ye Sen, Zhang Shuhua, Yang Mingwen, Zhu Tiantian, Kong Deyu, Chen Jun, Xu Lei, Li Jimin, Zhu Hui, Wang Fei, Yang Lu, Zhang Jing, Fan Yuansheng, Ying Lianghong, Hu Xianqing, Zhang Xiaofeng, Chan Noel C, Li Chunji |
Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary Intervention: The TAILOR-PCI Randomized Clinical Trial. JAMA 2020 08 324 (8): 761-771. Pereira Naveen L, Farkouh Michael E, So Derek, Lennon Ryan, Geller Nancy, Mathew Verghese, Bell Malcolm, Bae Jang-Ho, Jeong Myung Ho, Chavez Ivan, Gordon Paul, Abbott J Dawn, Cagin Charles, Baudhuin Linnea, Fu Yi-Ping, Goodman Shaun G, Hasan Ahmed, Iturriaga Erin, Lerman Amir, Sidhu Mandeep, Tanguay Jean-Francois, Wang Liewei, Weinshilboum Richard, Welsh Robert, Rosenberg Yves, Bailey Kent, Rihal Charanj |
CYP2C19, PON1, and ABCB1 gene polymorphisms in Han and Uygur populations with coronary artery disease in Northwestern Xinjiang, China, From 2014 Through 2019. Medicine 2020 Jul 99 (29): e20582. Wang Tingting, Zhao Ting, Bao Sichen, Jia Li, Feng Jie, Yu Aiping, Sun Li, Guo Xihong, Li Hongjian, Yu Luh |
Genomewide Association Study of Platelet Reactivity and Cardiovascular Response in Patients Treated With Clopidogrel: A Study by the International Clopidogrel Pharmacogenomics Consortium.
Clinical pharmacology and therapeutics 2020 May . Verma Shefali Setia, Bergmeijer Thomas O, Gong Li, Reny Jean-Luc, Lewis Joshua P, Mitchell Braxton D, Alexopoulos Dimitrios, Aradi Daniel, Altman Russ B, Bliden Kevin, Bradford Yuki, Campo Gianluca, Chang Kiyuk, Cleator John H, Déry Jean-Pierre, Dridi Nadia P, Fernandez-Cadenas Israel, Fontana Pierre, Gawaz Meinrad, Geisler Tobias, Gensini Gian Franco, Giusti Betti, Gurbel Paul A, Hochholzer Willibald, Holmvang Lene, Kim Eun-Young, Kim Ho-Sook, Marcucci Rossella, Montaner Joan, Backman Joshua D, Pakyz Ruth E, Roden Dan M, Schaeffeler Elke, Schwab Matthias, Shin Jae Gook, Siller-Matula Jolanta M, Ten Berg Jurriën M, Trenk Dietmar, Valgimigli Marco, Wallace John, Wen Ming-Shien, Kubo Michiaki, Lee Ming Ta Michael, Whaley Ryan, Winter Stefan, Klein Teri E, Shuldiner Alan R, Ritchie Marylyn D, |
Validation of the ABCD-GENE score to identify high platelet reactivity in east Asian patients undergoing percutaneous coronary intervention. International journal of cardiology 2020 11 327 15-18. Saito Yuichi, Nishi Takeshi, Wakabayashi Shinichi, Ohno Yuji, Kitahara Hideki, Ariyoshi Noritaka, Kobayashi Yosh |
Association of FMO3 rs1736557 polymorphism with clopidogrel response in Chinese patients with coronary artery disease. European journal of clinical pharmacology 2020 Oct . Zhu Kong-Xiang, Song Pei-Yuan, He-Li , Li Mu-Peng, Du Yin-Xiao, Ma Qi-Lin, Peng Li-Ming, Chen Xiao-Pi |
Cardiovascular Pharmacogenomics: An Update on Clinical Studies of Antithrombotic Drugs in Brazilian Patients. Molecular diagnosis & therapy 2021 8 25 (6): 735-755. Hirata Thiago Dominguez Crespo, Dagli-Hernandez Carolina, Genvigir Fabiana Dalla Vecchia, Lauschke Volker Martin, Zhou Yitian, Hirata Mario Hiroyuki, Hirata Rosario Dominguez Cres |
The influence of acute coronary syndrome on levels of clopidogrel active metabolite and platelet inhibition in patients with and without CYP2C19*2(681 G>A), *3(636 G>A) and ABCB1(C3435C> T) gene polymorphisms. Postepy w kardiologii interwencyjnej = Advances in interventional cardiology 2021 Jun 17 (2): 179-186. Wójcik Tomasz, Karolko Bo?ena, Wi?niewski Jerzy, Mysiak Andrzej, ?ciborski Krzysztof, Onisk Grzegorz, Lebioda Arleta, Jonkisz Anna, Protasiewicz Marc |
Differential Impact of Clinical and Genetic Factors on High Platelet Reactivity in Patients with Coronary Artery Disease Treated with Clopidogrel and Prasugrel. Journal of atherosclerosis and thrombosis 2021 7 29 (7): 1031-1039. Saito Yuichi, Nishi Takeshi, Wakabayashi Shinichi, Ohno Yuji, Kitahara Hideki, Ariyoshi Noritaka, Kobayashi Yosh |
Risk of stroke in CYP2C19 LoF polymorphism carrier coronary artery disease patients undergoing clopidogrel therapy: An ethnicity-based updated meta-analysis. European journal of internal medicine 2021 Jun . Jafrin Sarah, Naznin Nura Ershad, Reza Md Sharif, Aziz Md Abdul, Islam Mohammad Safiq |
Effect of CYP2C19 Genotype on Ischemic Outcomes During Oral P2Y Inhibitor Therapy: A Meta-Analysis. JACC. Cardiovascular interventions 2021 Apr 14 (7): 739-750. Pereira Naveen L, Rihal Charanjit, Lennon Ryan, Marcus Gil, Shrivastava Sanskriti, Bell Malcolm R, So Derek, Geller Nancy, Goodman Shaun G, Hasan Ahmed, Lerman Amir, Rosenberg Yves, Bailey Kent, Murad M Hassan, Farkouh Michael |
Association of CYP2C19 Loss-of-Function Alleles with Major Adverse Cardiovascular Events of Clopidogrel in Stable Coronary Artery Disease Patients Undergoing Percutaneous Coronary Intervention: Meta-analysis. Cardiovascular drugs and therapy 2021 2 35 (6): 1147-1159. Biswas Mohitosh, Kali Sumaiya Khat |
Physiologically-Based Pharmacokinetic-Pharmacodynamics Model Characterizing CYP2C19 Polymorphisms to Predict Clopidogrel Pharmacokinetics and Its Anti-Platelet Aggregation Effect Following Oral Administration to Coronary Artery Disease Patients With or Without Diabetes. Frontiers in pharmacology 2021 2 11 593982. Xu Ru-Jun, Kong Wei-Min, An Xiao-Fei, Zou Jian-Jun, Liu Li, Liu Xiao-Do |
Influence of GAS5/MicroRNA-223-3p/P2Y12 Axis on Clopidogrel Response in Coronary Artery Disease. Journal of the American Heart Association 2021 Oct e021129. Liu Yan-Ling, Hu Xiao-Lei, Song Pei-Yuan, Li He, Li Mu-Peng, Du Yin-Xiao, Li Mo-Yun, Ma Qi-Lin, Peng Li-Ming, Song Ming-Yu, Chen Xiao-Pi |
Platelet Function and Genotype after DES Implantation in East Asian Patients: Rationale and Characteristics of the PTRG-DES Consortium. Yonsei medical journal 2022 May 63 (5): 413-421. Her Ae-Young, Jeong Young-Hoon, Kim Byeong-Keuk, Joo Hyung Joon, Chang Kiyuk, Park Yongwhi, Song Young Bin, Ahn Sung Gyun, Suh Jung-Won, Lee Sang Yeup, Cho Jung Rae, Kim Hyo-Soo, Kim Moo Hyun, Lim Do-Sun, Shin Eun-Seok, |
Antiplatelet effect, safety, and pharmacokinetics of vicagrel in patients with coronary artery disease undergoing percutaneous coronary intervention. European heart journal. Cardiovascular pharmacotherapy 2022 4 8 (8): 806-814. Zhao Xin, Ma Sicong, Kang Yi, Tang Chengchun, Liu Bin, Jiang Hong, Zheng Mingqi, Tang Yu, Sun Hongbin, Liu Yongqiang, Lai Xiaojuan, Gong Yanchun, Li Yongguo, Qi Zizhao, Ren Ling, Li Jing, Li Yi, Han Yali |
Analysis of the Guiding Role of CYP2C19 Gene Combined With Platelet Function Detection in Antiplatelet Therapy in Patients With Complex Coronary Artery Disease After PCI. Frontiers in surgery 2022 2 9 839157. Yu Jiancai, Liu Yongxing, Peng Wanzhong, Liu Juan, Li Ya, Liu Junyan, Jiang Yang, Liu Demin, Xu Zeshe |
Comparative evaluation of standard maintenance-dose clopidogrel versus low-dose prasugrel in patients with stable coronary artery disease after percutaneous coronary intervention. International journal of cardiology 2022 2 356 30-35. Akimaru Kaoru, Iwabuchi Masashi, Ishida Akio, Uehara Hiroki, Higa Namio, Kakazu Masanori, Wake Minoru, Maeda Taketoshi, Maeda Toshiki, Arima Hisatomi, Ohya Yusuke, , Tokashiki Shinta, Wakugawa Hayashi, Miyagi Ayane, Shiohira Shinya, Zaima Satoshi, Shiohira Tomohiro, Toma Yuichirou, Ikemiyagi Hideka |
Prevalence of CYP2C19 Gene Polymorphism in Patients with Coronary Artery Disease Undergoing Percutaneous Coronary Intervention. European cardiology 2022 2 16 e61. Amalia Maya Rosana, Herminingsih Su |
Association of ABCC2 polymorphism with clopidogrel response in Chinese patients undergoing percutaneous coronary intervention. Frontiers in pharmacology 2022 10 13 889473. Chen Lida, Zheng Chao, Hao Mengmeng, Gao Peng, Zhao Meimei, Cao Yongtong, Ma Lia |
Differences in the Proportion of CYP2C19 Loss-of-Function Between Cerebral Infarction and Coronary Artery Disease Patients. International journal of general medicine 2023 8 16 3473-3481. Yuliang Shi, Yuxian Yang, Miaoling Feng, Weihan Ling, Tongguo Wei, Yumin Cao, Rui Zhong, Heming |
Decreased platelet miR-199a-5p level might lead to high on-clopidogrel platelet reactivity in patients with coronary artery disease. Platelets 2023 4 34 (1): 2200860. Xiaolei Hu, Mupeng Li, He Li, Peiyuan Song, Yanjiao Zhang, Gan Zhou, Jie Tang, Liming Peng, Qilin Ma, Xiaoping Ch |
Cytochrome P450 2C19 Polymorphisms and Its Association With Major Adverse Cardiac Events in Post-coronary Intervention Patients on Clopidogrel in the Tertiary Care Center. Cureus 2023 3 15 (2): e34737. Kambhampati Nikhil Teja, Ahamed Hisham, K K Velayudhan, David Sachin, Hakeem Sai Chandra, Pillai Gopalakrishna, Kartha Nivedit |
Influence of CYP2C19 genetic variants and smoking on dual antiplatelet efficacy in patients with coronary artery disease. Frontiers in cardiovascular medicine 2023 2 10 1105001. Cheng Yujing, Sun Yan, Zhang Dai, Ma Xiaoteng, Liu Chi, Hu Chengping, Sun Tienan, Zhao Ziwei, Liu Xiaoli, Zhou Yuj |
Utility of the ACD-GENE-CLI Score in Asian Patients with Critical Limb Ischemia Undergoing Endovascular Interventions. Journal of atherosclerosis and thrombosis 2023 12 . Wei-Ting Chang, Po-Sen Huang, Li-Wei Su, Chia-Te Liao, Han Siong Toh, Yi-Chen Chen, Chung-Han Ho, Zhih-Cherng Chen, Po-Chao Hsu, Chon-Seng Ho |
Pharmacogenomic evaluation of CYP2C19 alleles linking low clopidogrel response and the risk of acute coronary syndrome in Indians. The journal of gene medicine 2023 11 e3634. Keshavamurthy Ganapathy Bhat, Ratheesh Kumar Janardhana Pillai, Heemanshu Lodhi, Vivek Singh Guleria, Anil Kumar Abbot, Love Gupta, Garima Rastogi, Anuka Sharma, Zafar Mohammed, Varun Shar |
CYP2C19 metabolizer phenotypes may affect the efficacy of statins on lowering small dense low-density lipoprotein cholesterol of patients with coronary artery disease. Frontiers in cardiovascular medicine 2023 1 9 1016126. Dai Ruozhu, Zhao Xiaoyu, Zhuo Huilin, Wang Wei, Xu Yue, Hu Zixin, Zhang Tiexu, Zhao Jiangm |
Prevalence of CYP2C19*2 and CYP2C19*3 Allelic Variants and Clopidogrel Use in Patients with Cardiovascular Disease in Trinidad & Tobago. Cardiology and therapy 2024 1 . Daniele Jones, Shana Persad-Ramdeensingh, Sheherazade Crystal Abrahim, Naveen Seecheran, Rajini Rani Haraksin |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 06, 2024
- Content source: